NV-5138

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameNV-5138
Drug Alias NameNV-5138SPN-820
ClassificationSmall molecules
Mechanisms of ActionMammalian target of Rapamycin (mTORC1) stimulants
TargetsMammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNavitor Pharmaceuticals IncX-Chem Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavitor Pharmaceuticals IncSupernus Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia